Skip to content

Precision Therapy in Complex High-risk Coronary Artery Disease

Prospective Registry of the Intracoronary Physiology and Imaging-guided Precision Therapy in Complex High-risk Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04444960
Acronym
PTCA
Enrollment
1000
Registered
2020-06-24
Start date
2020-07-01
Completion date
2023-12-31
Last updated
2020-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

This is a prospective registry to enroll complex high-risk coronary heart disease patients. The purpose of this study is to compare intracoronary physiology and imaging-guided intervention strategy and angiography-guided intervention strategy for clinical outcomes and health economics.

Interventions

PROCEDUREpercutaneous coronary intervention

Intracoronary physiology and imaging-guided intervention strategy versus angiography-guided intervention strategy for complex high-risk coronary heart disease patients

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Bifurcation lesions with branch diameter ≥2.5mm; * Chronic complete occlusion (occlusion duration ≥3 months); * Left main disease; * Long lesions (≥38mm); * Multi-vessel percutaneous coronary intervention (simultaneous treatment of ≥2 epicardial vessels during one operation); * Multi-stent implantation (≥3 stents); * In-stent restenosis; * Moderate to severe calcification on radiography; * Intermediate lesion; * Thrombotic lesions; * Creatinine clearance rate \< 60ml/min) or on dialysis ; * Left ventricular ejection fraction \<40% ; * History of cerebral hemorrhage or massive hemorrhage of gastrointestinal tract.

Exclusion criteria

* Informed consent cannot be obtained; * Life expectancy \< 1 year.

Design outcomes

Primary

MeasureTime frameDescription
Composite ischemic events24 monthsComposite ischemic event is defined as the composite of cardiac death, stent thrombosis, nonfatal myocardial infarction or ischemic driven revascularization.

Countries

China

Contacts

Primary ContactXin Huang, PhD
hearthx@126.com008613571961135

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026